Matching samples

SAMPLE 1

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333765
sample_title: SAMPLE 1
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: None

SAMPLE 2

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333766
sample_title: SAMPLE 2
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 3

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333767
sample_title: SAMPLE 3
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 4

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333768
sample_title: SAMPLE 4
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 5

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333769
sample_title: SAMPLE 5
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 6

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333770
sample_title: SAMPLE 6
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 7

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333771
sample_title: SAMPLE 7
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 8

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333772
sample_title: SAMPLE 8
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 9

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333773
sample_title: SAMPLE 9
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: None; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: Moderate

SAMPLE10

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333774
sample_title: SAMPLE10
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 11

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333775
sample_title: SAMPLE 11
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 12

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333776
sample_title: SAMPLE 12
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: None

SAMPLE 13

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333777
sample_title: SAMPLE 13
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 14

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333778
sample_title: SAMPLE 14
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 15

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333779
sample_title: SAMPLE 15
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: None

SAMPLE 16

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333780
sample_title: SAMPLE 16
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 17

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333781
sample_title: SAMPLE 17
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 18

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333782
sample_title: SAMPLE 18
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 19

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333783
sample_title: SAMPLE 19
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 20

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333784
sample_title: SAMPLE 20
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 21

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333785
sample_title: SAMPLE 21
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 22

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333786
sample_title: SAMPLE 22
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 23

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333787
sample_title: SAMPLE 23
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 24

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333788
sample_title: SAMPLE 24
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 25

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333789
sample_title: SAMPLE 25
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 26

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333790
sample_title: SAMPLE 26
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 27

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333791
sample_title: SAMPLE 27
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 28

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333792
sample_title: SAMPLE 28
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 29

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333793
sample_title: SAMPLE 29
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: None

SAMPLE 30

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333794
sample_title: SAMPLE 30
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 31

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333795
sample_title: SAMPLE 31
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 32

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333796
sample_title: SAMPLE 32
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 33

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333797
sample_title: SAMPLE 33
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 34

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333798
sample_title: SAMPLE 34
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 35

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333799
sample_title: SAMPLE 35
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 36

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333800
sample_title: SAMPLE 36
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 37

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333801
sample_title: SAMPLE 37
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 38

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333802
sample_title: SAMPLE 38
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 39

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333803
sample_title: SAMPLE 39
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Moderate

SAMPLE 40

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333804
sample_title: SAMPLE 40
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: None

SAMPLE 41

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333805
sample_title: SAMPLE 41
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 42

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333806
sample_title: SAMPLE 42
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 43

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333807
sample_title: SAMPLE 43
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 44

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333808
sample_title: SAMPLE 44
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 45

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333809
sample_title: SAMPLE 45
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 46

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333810
sample_title: SAMPLE 46
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: None

SAMPLE 47

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333811
sample_title: SAMPLE 47
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: None

SAMPLE 48

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333812
sample_title: SAMPLE 48
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 49

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333813
sample_title: SAMPLE 49
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 50

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333814
sample_title: SAMPLE 50
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 51

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333815
sample_title: SAMPLE 51
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 52

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333816
sample_title: SAMPLE 52
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 53

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333817
sample_title: SAMPLE 53
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 54

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333818
sample_title: SAMPLE 54
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 55

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333819
sample_title: SAMPLE 55
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 56

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333820
sample_title: SAMPLE 56
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 57

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333821
sample_title: SAMPLE 57
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 58

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333822
sample_title: SAMPLE 58
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 59

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333823
sample_title: SAMPLE 59
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 60

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333824
sample_title: SAMPLE 60
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 61

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333825
sample_title: SAMPLE 61
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 62

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333826
sample_title: SAMPLE 62
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 63

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333827
sample_title: SAMPLE 63
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 64

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333828
sample_title: SAMPLE 64
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 65

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333829
sample_title: SAMPLE 65
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Moderate

SAMPLE 66

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333830
sample_title: SAMPLE 66
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 67

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333831
sample_title: SAMPLE 67
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 68

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333832
sample_title: SAMPLE 68
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 69

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333833
sample_title: SAMPLE 69
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 70

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333834
sample_title: SAMPLE 70
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 71

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333835
sample_title: SAMPLE 71
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 72

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333836
sample_title: SAMPLE 72
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 73

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333837
sample_title: SAMPLE 73
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 74

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333838
sample_title: SAMPLE 74
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 75

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333839
sample_title: SAMPLE 75
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 76

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333840
sample_title: SAMPLE 76
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 77

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333841
sample_title: SAMPLE 77
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 78

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333842
sample_title: SAMPLE 78
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 79

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333843
sample_title: SAMPLE 79
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 80

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333844
sample_title: SAMPLE 80
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 81

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333845
sample_title: SAMPLE 81
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 82

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333846
sample_title: SAMPLE 82
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 83

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333847
sample_title: SAMPLE 83
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 84

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333848
sample_title: SAMPLE 84
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Severe; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 85

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333849
sample_title: SAMPLE 85
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 86

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333850
sample_title: SAMPLE 86
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 87

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333851
sample_title: SAMPLE 87
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: None; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 88

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333852
sample_title: SAMPLE 88
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 89

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333853
sample_title: SAMPLE 89
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 90

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333854
sample_title: SAMPLE 90
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 91

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333855
sample_title: SAMPLE 91
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: None; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: None

SAMPLE 92

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333856
sample_title: SAMPLE 92
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 93

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333857
sample_title: SAMPLE 93
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 94

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333858
sample_title: SAMPLE 94
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 95

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333859
sample_title: SAMPLE 95
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 96

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333860
sample_title: SAMPLE 96
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: None; portal inflammation: Mild

SAMPLE 97

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333861
sample_title: SAMPLE 97
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 98

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333862
sample_title: SAMPLE 98
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Moderate

SAMPLE 99

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333863
sample_title: SAMPLE 99
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 100

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333864
sample_title: SAMPLE 100
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 101

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333865
sample_title: SAMPLE 101
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 102

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333866
sample_title: SAMPLE 102
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 103

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333867
sample_title: SAMPLE 103
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 104

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333868
sample_title: SAMPLE 104
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: None

SAMPLE 105

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333869
sample_title: SAMPLE 105
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 106

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333870
sample_title: SAMPLE 106
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 107

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333871
sample_title: SAMPLE 107
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 108

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333872
sample_title: SAMPLE 108
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 109

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333873
sample_title: SAMPLE 109
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: None

SAMPLE 110

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333874
sample_title: SAMPLE 110
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 111

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333875
sample_title: SAMPLE 111
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 112

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333876
sample_title: SAMPLE 112
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 113

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333877
sample_title: SAMPLE 113
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 0; lobular inflammation: Mild; portal inflammation: None

SAMPLE 114

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333878
sample_title: SAMPLE 114
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 115

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333879
sample_title: SAMPLE 115
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 116

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333880
sample_title: SAMPLE 116
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Moderate; perivenular fibrosis: Moderate; ishak fibrosis stage: 3; lobular inflammation: Mild; portal inflammation: Moderate

SAMPLE 117

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333881
sample_title: SAMPLE 117
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: None

SAMPLE 118

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333882
sample_title: SAMPLE 118
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Moderate; ishak fibrosis stage: 2; lobular inflammation: Moderate; portal inflammation: Moderate

SAMPLE 119

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333883
sample_title: SAMPLE 119
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 120

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333884
sample_title: SAMPLE 120
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 121

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333885
sample_title: SAMPLE 121
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 122

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333886
sample_title: SAMPLE 122
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 123

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333887
sample_title: SAMPLE 123
source_name: Screening Visit_Cluster 2
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 2; interface activity: None; perivenular fibrosis: Moderate; ishak fibrosis stage: 1; lobular inflammation: Mild; portal inflammation: Mild

SAMPLE 124

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333888
sample_title: SAMPLE 124
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 3; lobular inflammation: None; portal inflammation: Mild

SAMPLE 125

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333889
sample_title: SAMPLE 125
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 126

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333890
sample_title: SAMPLE 126
source_name: Screening Visit_Cluster 1
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 1; interface activity: Mild; perivenular fibrosis: Mild; ishak fibrosis stage: 2; lobular inflammation: None; portal inflammation: Mild

SAMPLE 127

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333891
sample_title: SAMPLE 127
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: Mild

SAMPLE 128

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM3333892
sample_title: SAMPLE 128
source_name: Screening Visit_Cluster 3
characteristics: tissue: Liver Biopsy; histological clusters: Cluster 3; interface activity: None; perivenular fibrosis: Mild; ishak fibrosis stage: 1; lobular inflammation: None; portal inflammation: None

SAMPLE 129

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. specimen category excludes: Biofluid — Insufficient evidence. Study role: Case marker detected.